Discrepancy between radiological and pathological size of renal masses
Open Access
- 22 February 2011
- journal article
- research article
- Published by Springer Nature in BMC Urology
- Vol. 11 (1) , 2
Abstract
Background: Tumor size is a critical variable in staging for renal cell carcinoma. Clinicians rely on radiological estimates of pathological tumor size to guide patient counseling regarding prognosis, choice of treatment strategy and entry into clinical trials. If there is a discrepancy between radiological and pathological measurements of renal tumor size, this could have implications for clinical practice. Our study aimed to compare the radiological size of solid renal tumors on computed tomography (CT) to the pathological size in an Australian population.Methods: We identified 157 patients in the Westmead Renal Tumor Database, for whom data was available for both radiological tumor size on CT and pathological tumor size. The paired Student'st-test was used to compare the mean radiological tumor size and the mean pathological tumor size. Statistical significance was defined asP< 0.05. We also identified all cases in which post-operative down-staging or up-staging occurred due to discrepancy between radiological and pathological tumor sizes. Additionally, we examined the relationship between Fuhrman grade and radiological tumor size and pathological T stage.Results: Overall, the mean radiological tumor size on CT was 58.3 mm and the mean pathological size was 55.2 mm. On average, CT overestimated pathological size by 3.1 mm (P= 0.012). CT overestimated pathological tumor size in 92 (58.6%) patients, underestimated in 44 (28.0%) patients and equaled pathological size in 21 (31.4%) patients. Among the 122 patients with pT1 or pT2 tumors, there was a discrepancy between clinical and pathological staging in 35 (29%) patients. Of these, 21 (17%) patients were down-staged post-operatively and 14 (11.5%) were up-staged. Fuhrman grade correlated positively with radiological tumor size (P= 0.039) and pathological tumor stage (P= 0.003).Conclusions: There was a statistically significant but small difference (3.1 mm) between mean radiological and mean pathological tumor size, but this is of uncertain clinical significance. For some patients, the difference leads to a discrepancy between clinical and pathological staging, which may have implications for pre-operative patient counseling regarding prognosis and management.Keywords
This publication has 51 references indexed in Scilit:
- Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical seriesBJU International, 2010
- EAU Guidelines on Renal Cell Carcinoma: The 2010 UpdateEuropean Urology, 2010
- Correlation between Radiologic and Pathologic Tumor Size in Localized Renal Cell CarcinomaKorean Journal of Urology, 2010
- Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma CasesJournal of Urology, 2009
- Partial Nephrectomy Versus Radical Nephrectomy in Patients With Small Renal Tumors—Is There a Difference in Mortality and Cardiovascular Outcomes?Journal of Urology, 2009
- Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size?BJU International, 2008
- Implications of computer tomography measurement in the management of renal tumoursBMC Urology, 2008
- Outcomes Following Partial Nephrectomy by Tumor SizeJournal of Urology, 2008
- Prognostic variables to predict cancer‐related death in incidental renal tumoursBJU International, 2008
- Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2007